@atarabio.com
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
PNG
About
Description
Atara Biotherapeutics is a pioneering brand in the field of off-the-shelf, allogeneic T-cell immunotherapy. They are dedicated to developing groundbreaking treatments for patients with cancer, autoimmune diseases, and viral diseases. By harnessing the natural power of T cells, which are the body's most effective defense against diseases, Atara Biotherapeutics is revolutionizing the realm of medical therapies.
One of the key advantages of their approach is the off-the-shelf nature of their therapies, meaning they can be readily available for rapid delivery within days. Another strength lies in their scalable manufacturing process, which allows them to produce over a thousand doses from just one healthy donor. This allows for efficient, widespread treatment options for patients in need.
Furthermore, their versatile platform has the potential to address a wide range of disease-causing viral and non-viral targets. Atara Biotherapeutics is at the forefront of innovation, with an impressive pipeline of firsts in the industry. They have pioneered investigational T-cell therapies that target challenging Epstein-Barr virus (EBV)-driven conditions, including certain cancers and multiple sclerosis, as well as various non-EBV-associated diseases.
Continuously pushing the boundaries of medical science, Atara Biotherapeutics is driven by their mission to unleash the promise of T-cell therapies and create transformative treatments for patients around the world
Company Type
Public Company
Company Size
201-500
Year Founded
2012
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories